Galecto Biotech
DenmarkEntry
2018
Hold
8yr
Status
Active
Who owns Galecto Biotech?
Galecto Biotech is a Danish Biotech company, currently owned by Seventure Partners since 2018.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Most recent investor
Seventure PartnersQuadrivium 1 Seed Fund · 2013 · VC
2 ownership periods · full history below
Key facts
HQDenmark
SectorBiotech
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2018 · present
Ysios Capital PartnersExited 2020
2018 · 2020(2yr) · Ysios BioFund I · 2008 · Life Sciences VC
IPO
Ysios Capital Partners took Galecto Biotech public via IPO in 2020 after 2 years.
Seventure PartnersActive
2018 · present(8yr) · Quadrivium 1 Seed Fund · 2013 · VC
More from Quadrivium 1 Seed Fund
Other portfolio companies in the same fund.
France
UK
Germany
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Galecto Biotech?
Galecto Biotech is currently owned by Seventure Partners, through Quadrivium 1 Seed Fund, since 2018.
When did Seventure Partners acquire Galecto Biotech?
Seventure Partners acquired Galecto Biotech in 2018.
Who has owned Galecto Biotech over time?
Galecto Biotech has been through 2 private-equity ownership periods: Ysios Capital Partners · via Ysios BioFund I · 2018–2020 · (IPO); Seventure Partners · via Quadrivium 1 Seed Fund · since 2018.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue